Last edition
News about "Dr. Xiaoxiang Chen"
Tenacia and Golden Age Health Partner to Commercialise Ztalmy for CDKL5 Deficiency Disorder in China
Tenacia Biopharmaceuticals has granted Golden Age Health exclusive rights to commercialise Ztalmy, the first approved therapy for CDKL5 deficiency disorder, in Mainland China.
Dr. Xiaoxiang Chen | 03/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members